Loading…
Loading…
4169.TWO (TCM Biotech International Corp.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.

| 4771.TW | Vizionfocus Inc. | NT$207.50 | NT$12.2B |
| 1720.TW | Standard Chem & Pharm Co. Ltd. | NT$57.10 | NT$11.2B |
| 6945.TWO | AP Biosciences Inc | NT$101.50 | NT$9.8B |
| 4162.TWO | PharmaEngine, Inc. | NT$60.10 | NT$8.6B |
| 4107.TWO | Bioteque Corporation | NT$114.00 | NT$7.9B |
| 4142.TW | Adimmune Corporation | NT$18.00 | NT$7.6B |
| 6499.TWO | Medeon Biodesign, Inc. | NT$71.50 | NT$6.9B |
| 6976.TWO | Acepodia, Inc. | NT$11.75 | NT$6.8B |
| 4746.TW | Formosa Laboratories, Inc. | NT$49.35 | NT$5.9B |
| 4164.TW | CHC Healthcare Group | NT$26.55 | NT$5.2B |